GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Mitsubishi Chemical Group Corp (TSE:4188) » Definitions » 5-Year EBITDA Growth Rate

Mitsubishi Chemical Group (TSE:4188) 5-Year EBITDA Growth Rate : 0.00% (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Mitsubishi Chemical Group 5-Year EBITDA Growth Rate?

Mitsubishi Chemical Group's EBITDA per Share for the three months ended in Dec. 2023 was 円98.06.

During the past 12 months, Mitsubishi Chemical Group's average EBITDA Per Share Growth Rate was 53.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 7.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Mitsubishi Chemical Group was 44.60% per year. The lowest was -15.50% per year. And the median was 2.80% per year.


Competitive Comparison of Mitsubishi Chemical Group's 5-Year EBITDA Growth Rate

For the Specialty Chemicals subindustry, Mitsubishi Chemical Group's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mitsubishi Chemical Group's 5-Year EBITDA Growth Rate Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Mitsubishi Chemical Group's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Mitsubishi Chemical Group's 5-Year EBITDA Growth Rate falls into.



Mitsubishi Chemical Group 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Mitsubishi Chemical Group  (TSE:4188) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Mitsubishi Chemical Group 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Mitsubishi Chemical Group's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Mitsubishi Chemical Group (TSE:4188) Business Description

Traded in Other Exchanges
Address
1-1 Marunouchi 1-chome, Chiyoda-ku, Tokyo, JPN, 100-8251
Mitsubishi Chemical Group Corp is a holdings company, which manufactures and sells chemicals, plastics, and pharmaceuticals. It organizes itself into three segments based on product. The Industrial Materials segment, which generates the majority of revenue, sells chemicals and polymers, including industrial gases, petrochemicals, thermoplastics, polyethylene, and polypropylene. The Performance Products segment sells electronics and designed materials, including LED lighting and equipment, specialty chemicals, polyester and industrial films, and fibers. The Health Care segment sells pharmaceuticals to treat autoimmune diseases, diabetes and kidney diseases, central nervous system treatments, and vaccines. The majority of revenue comes from Japan.

Mitsubishi Chemical Group (TSE:4188) Headlines

No Headlines